SLCO1B1 and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome: The physician of another patient in the control group with the decreased SLCO1B1 transporter function T/C genotype documented possible SAMS with an atorvastatin dose of 20 mg, before the patient or physician knew the genotype results.